Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach

Cancer immunotherapy has gained traction in recent years owing to remarkable tumor clearance in some patients. Despite the notable success of immune checkpoint blockade (ICB) in multiple malignancies, engagement of the immune system for targeted prostate cancer (PCa) therapy is still in its infancy....

Descripción completa

Detalles Bibliográficos
Autores principales: Sridaran, Dhivya, Bradshaw, Elliot, DeSelm, Carl, Pachynski, Russell, Mahajan, Kiran, Mahajan, Nupam P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591038/
https://www.ncbi.nlm.nih.gov/pubmed/37738978
http://dx.doi.org/10.1016/j.xcrm.2023.101199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591038/
https://www.ncbi.nlm.nih.gov/pubmed/37738978
http://dx.doi.org/10.1016/j.xcrm.2023.101199

Ejemplares similares